pharmaphorum
MAY 4, 2022
Testing drug compounds on a chip designed to mimic human organs sounds closer to science fiction than reality, yet the technology already exists and is already being put to use. Ben Hargreaves discovers how the technology could provide more accurate safety predictions and even discover new treatments. The limits of animal models in drug discovery are well known.
Outsourcing Pharma
MAY 4, 2022
CPhI North America 2022 host city Philadelphia is set to become one of the worldâs biggest cell and gene therapy manufacturing hubs. But itâs just one of many centers of innovation that are helping drive the US pharma and biopharma industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 4, 2022
Cognitive problems affecting memory and attention can be substantial and long-lasting in patients who suffer severe COVID-19 infections, according to a study by researchers in the UK. The study used computerised cognitive assessments to follow-up 46 people who were hospitalised with COVID-19 at the Addenbrooke’s Hospital in Cambridge over a three-month period in 2020, comparing the results with 460 matched control subjects.
Outsourcing Pharma
MAY 4, 2022
An expert from Pharmatech Associates offers a glimpse into the evolution of CM and previews a lively discussion during the upcoming CPhI North America event.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 4, 2022
Hello Heart has raised $70 million in fourth-round financing to help grow its smartphone-based technology for people seeking to improve their heart health. Hello Heart blood pressure monitor. Hello Heart’s digital platform is based on a blood pressure monitor and smartphone app. It deploys artificial intelligence to help users track their blood pressure, pulse rate, weight and activity levels – as well as any medications taken – and give feedback and advice on how to adopt healthy practice
Impact Pharmaceutical Services
MAY 4, 2022
May 4, 2022 | Nathaniel DiTommaso, MS, Regulatory Affairs Manager. In May of 2014 and February of 2019 , the FDA released final Guidance for Industry outlining the Agency’s policies and procedures regarding expedited development and review programs for new drugs and biologics intended to treat serious or life-threatening conditions. Image courtesy of qimono at pixabay.com.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Impact Pharmaceutical Services
MAY 4, 2022
May 4, 2022 | Nathaniel DiTommaso, MS, Regulatory Affairs Manager | Regulatory Affairs | Drug Development Consulting In May of 2014 and February of 2019, the FDA released final Guidance for Industry outlining the Agency’s policies and procedures regarding expedited development and review programs for new drugs and biologics intended to treat serious or life-threatening […].
pharmaphorum
MAY 4, 2022
SAE Media Group’s 3rd Annual Conference. Pre-Filled Syringes San Francisco. September 19 – 20, 2022 | San Francisco, CA, USA. ————————————————————————-. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, a
Outsourcing Pharma
MAY 4, 2022
An expert from the organization discusses ahead of his CPhI North America presentation how tomorrowâs drugs canât all be formulated with yesterdayâs excipients.
pharmaphorum
MAY 4, 2022
Novartis’ CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences’ rival Yescarta. Follicular lymphoma is the second most common form of non-Hodgkin lymphoma (NHL), and is a slow developing but incurable disease that represents around 22% of NHL cases.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
MAY 4, 2022
A leader from the organizer of the pharmaceutical event discusses whatâs in store for the upcoming conference, and for the drug development industry itself.
pharmaphorum
MAY 4, 2022
The FDA has kicked off a priority review of AstraZeneca’s checkpoint inhibitor Imfinzi for biliary tract cancer (BTC), setting up what could be approval for an immunotherapy for the group of rare and aggressive gastrointestinal tumours. The six-month review means that PD-L1 inhibitor Imfinzi (durvalumab) could get a verdict from the US regulator in the third quarter of the year.
Med Ed 101
MAY 4, 2022
As you may or may not be aware, Adderall and vitamin C can interact with each other. The primary issue for this drug interaction involves an alteration of Adderall’s gastrointestinal absorption. Having a more acidic gut environment can reduce the absorption of Adderall. Here’s my take on the Adderall vitamin C interaction and some questions […].
Pharma Times
MAY 4, 2022
Platform will enable patients to monitor and share updates of their post-surgical wound healing
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
MAY 4, 2022
Approval for Kymriah follows a positive CHMP opinion and is applicable to all 27 EU member states
Expert insights. Personalized for you.
142 
Let's personalize your content